🔎 Trials Near Me

Home › Chronic Progressive Multiple Sclerosis › Florida

Pag-aaral pangklinika para sa Chronic Progressive Multiple Sclerosis sa Florida

5 pag-aaral para sa Chronic Progressive Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa Florida.

Mga Lungsod sa Florida

Opisyal na teksto ng pag-aaral (English)

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  • SFM Clinical Research, LLC, Boca Raton
  • Nova Clinical Research, LLC, Bradenton
  • MS and Neuromuscular Center of Excellence, Clearwater
  • at 3 pa
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07299019

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  • Nova Clinical Research, LLC, Bradenton
  • Neurology Associates, PA, Maitland
  • Neurological Services of Orlando, Orlando
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07067463

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

  • Local Institution - Site 103, Tampa
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07840326

A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

  • Neurology Associates, PA, Maitland
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07609719

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Neurology of Central FL Res Ctr, Altamonte Springs
  • UF Health Cancer Center, Gainesville
  • Homestead Assoc In Research Inc, Homestead
  • at 8 pa
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07225504

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.